Esperion Therapeutics
Ann Arbor, Michigan, United States · Biotechnology, Health Care, Pharmaceutical
Esperion Therapeutics is a pharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative medicines for patients at risk for cardiovascular and cardiometabolic diseases.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Ann Arbor, Michigan, United States
- Employees
- 310
- Industries
- Biotechnology, Health Care, Pharmaceutical
- Website
- esperion.com
- Company page
Recent activity at Esperion Therapeutics
- : Esperion Therapeutics Announces Acquisition of Corstasis Therapeutics
- : Esperion Appoints John Harlow as Chief Commercial Officer
- : Esperion Enters into $210 Million Convertible Debt Financing Agreements (date Fundz recorded it)
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Employee benefit plans
Esperion Therapeutics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Esperion Therapeutics: questions and answers
What does Esperion Therapeutics do?
Esperion Therapeutics is a pharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative medicines for patients at risk for cardiovascular and cardiometabolic diseases.
Where is Esperion Therapeutics headquartered?
Esperion Therapeutics is headquartered in Ann Arbor, Michigan, United States.
How many employees does Esperion Therapeutics have?
Esperion Therapeutics has about 310 employees.
What is the latest news on Esperion Therapeutics?
On Mar 2, 2026, Esperion Therapeutics Announces Acquisition of Corstasis Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy